GO:0043257 laminin-411 trimer: Components, Assembly

The laminin-411 trimer (GO:0043257) is a heterotrimeric protein complex that is a key component of basement membranes in various tissues. It is composed of three polypeptide chains: alpha4, beta1, and gamma1, which assemble into a cross-shaped structure that mediates cell-matrix interactions. This complex, also known as laminin-8, plays critical roles in embryonic development, tissue homeostasis, and disease pathogenesis. Understanding its molecular functions and regulation is essential for researchers studying cell adhesion, migration, and signaling in both normal and pathological contexts. In cancer, laminin-411 has been associated with tumor progression, angiogenesis, and metastasis, making it a potential therapeutic target. Recent advances in nanobiotechnology have enabled the delivery of drugs specifically to laminin-411-rich tumor microenvironments, demonstrating its translational relevance. This article provides a comprehensive overview of the structure, function, and research methodologies related to the laminin-411 trimer, based on authoritative QuickGO data and published literature.

According to the Gene Ontology, GO:0043257 (laminin-411 trimer) is defined as a laminin complex composed of alpha4, beta1, and gamma1 polypeptide chains. It is a cellular component located in the basement membrane and extracellular matrix, where it forms a disulfide-bonded heterotrimer. The term is synonymous with laminin-411 complex and laminin-8 complex. This complex serves as an adhesive substrate for cells and modulates signaling pathways that control proliferation, differentiation, and survival.

The laminin-411 trimer is crucial for maintaining tissue architecture and regulating cellular behaviors such as adhesion, migration, and proliferation. Its aberrant expression is linked to cancer progression, angiogenesis, and tissue remodeling, making it a significant focus in biomedical research. Moreover, laminin-411 serves as a target for novel therapeutic strategies, including nanobioconjugates that deliver drugs to tumor sites. Understanding its biology can lead to new insights into development, wound healing, and disease mechanisms.

The following genes encode the subunits and interacting partners of the laminin-411 trimer, as well as related regulatory proteins.

The expression and assembly of the laminin-411 trimer are regulated at multiple levels, including transcriptional control by growth factors and cytokines, post-translational modifications, and proteolytic processing. For example, TGF-beta and VEGF can upregulate LAMA4 expression in endothelial cells during angiogenesis. Matrix metalloproteinases (MMPs) can cleave laminin-411, modulating its function and releasing bioactive fragments. Additionally, integrin-mediated signaling can feedback to regulate laminin expression.

Laminin-411 is overexpressed in various cancers, including glioblastoma, breast, and prostate cancer, where it promotes tumor cell proliferation, migration, and angiogenesis. It interacts with integrins to activate signaling pathways such as PI3K/Akt and MAPK, contributing to tumor progression. Targeting laminin-411 with nanobioconjugates has been shown to inhibit brain tumor growth in preclinical models.

Dysregulation of laminin-411 is associated with vascular pathologies such as atherosclerosis and restenosis. It influences endothelial cell behavior and smooth muscle cell migration, processes critical for vascular remodeling.

Mutations in LAMA4, LAMB1, or LAMC1 can lead to developmental defects, including muscular dystrophy and basement membrane abnormalities. Knockout mouse models have revealed essential roles in embryogenesis and organ development.

Genome-wide CRISPR knockout screens can identify genes that regulate laminin-411 expression or function. For example, knocking out candidate genes in cancer cells followed by laminin-411 staining or functional assays can reveal novel regulators.

Mass spectrometry-based proteomics can characterize the composition of laminin-411 complexes and identify post-translational modifications. Proximity labeling with tagged laminin subunits can map interacting proteins in living cells.

Immunofluorescence and live-cell imaging using fluorescently tagged laminin subunits can visualize assembly, secretion, and matrix deposition. Electron microscopy provides ultrastructural details of basement membrane networks.

Cell adhesion, migration, and proliferation assays on laminin-411-coated surfaces or in knockout cells can assess its biological roles. Angiogenesis tube formation assays are used to study its role in vascular biology.

Researchers studying laminin-411 trimer-related genes often need to determine whether a candidate gene is causally involved in its regulation or function. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.

The laminin-411 trimer (GO:0043257) is a critical basement membrane component with diverse roles in cell biology and disease. Its involvement in cancer, vascular biology, and development makes it a compelling target for research and therapeutic intervention. Advances in CRISPR technologies and nanomedicine are opening new avenues to study and target laminin-411, promising improved understanding and treatment of related disorders.